Applications of Toxicogenomics in Safety Evaluation and Risk Assessment
Herausgeber: Boverhof, Darrell R; Gollapudi, B Bhaskar
Applications of Toxicogenomics in Safety Evaluation and Risk Assessment
Herausgeber: Boverhof, Darrell R; Gollapudi, B Bhaskar
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book provides a timely overview of toxicogenomics, with special emphasis on the practical applications of this technology to the risk assessment process. Introductory sections are followed by a series of chapters highlighting practical and systematic applications of toxicogenomics in informing the risk assessment process - including the areas of mutagenicity, carcinogenicity, endocrine toxicity, organ-specific toxicity, population monitoring, and ecotoxicology. The book concludes with approaches for the integration of this technology in safety evaluation studies, and an outlook on how…mehr
Andere Kunden interessierten sich auch für
- Fundamental Neuropathology for Pathologists and Toxicologists188,99 €
- Quantitative Modeling in Toxicology184,99 €
- T. S. S. DikshithIndustrial Guide to Chemical and Drug Safety351,99 €
- Chemical Weapons Convention Chemicals Analysis657,99 €
- Vasant GowarikerThe Fertilizer Encyclopedia544,99 €
- Anticholinesterase Pesticides208,99 €
- Developmental Neurotoxicology Research208,99 €
-
-
-
This book provides a timely overview of toxicogenomics, with special emphasis on the practical applications of this technology to the risk assessment process. Introductory sections are followed by a series of chapters highlighting practical and systematic applications of toxicogenomics in informing the risk assessment process - including the areas of mutagenicity, carcinogenicity, endocrine toxicity, organ-specific toxicity, population monitoring, and ecotoxicology. The book concludes with approaches for the integration of this technology in safety evaluation studies, and an outlook on how toxicogenomics and complementary technologies can reframe the current risk assessment paradigm.
Produktdetails
- Produktdetails
- Verlag: John Wiley & Sons / Wiley
- Seitenzahl: 392
- Erscheinungstermin: 2. August 2011
- Englisch
- Abmessung: 240mm x 161mm x 26mm
- Gewicht: 768g
- ISBN-13: 9780470449820
- ISBN-10: 0470449829
- Artikelnr.: 32301979
- Verlag: John Wiley & Sons / Wiley
- Seitenzahl: 392
- Erscheinungstermin: 2. August 2011
- Englisch
- Abmessung: 240mm x 161mm x 26mm
- Gewicht: 768g
- ISBN-13: 9780470449820
- ISBN-10: 0470449829
- Artikelnr.: 32301979
DARRELL R. BOVERHOF, PhD, is a Senior Toxicology Specialist at The Dow Chemical Company where he leads research programs on respiratory allergy and sensitization, nanotoxicology, and toxicogenomics. Dr. Boverhof has authored or coauthored numerous peer-reviewed publications, review articles, and book chapters in the area of toxicogenomics and serves on the editorial board of the journal Toxicological Sciences. B. BHASKAR GOLLAPUDI, PhD, is the Scientific Director of Mammalian Toxicology at The Dow Chemical Company's Global Toxicology & Environmental Research Laboratory. Dr. Gollapudi has authored or co-authored more than 80 scientific publications. He is an Associate Editor of the journal Toxicological Sciences and is currently serving as an adjunct Associate Professor of Toxicology in the Department of Public Health at the University of Michigan.
PREFACE. CONTRIBUTORS. 1 TOXICOLOGY
"OMICS" TECHNOLOGIES
AND TOXICOGENOMICS: A PRIMER (Darrell R. Boverhof and B. Bhaskar Gollapudi). 2 INTRODUCTION TO HUMAN HEALTH RISK ASSESSMENT (Irene Baskerville-Abraham
Alison Willis
Bernard Gadagbui
and Lynne T. Haber). 3 PRACTICAL CONSIDERATIONS FOR THE APPLICATION OF TOXICOGENOMICS TO RISK ASSESSMENT: EARLY EXPERIENCE
CURRENT DRIVERS
AND A PATH FORWARD (Darrell R. Boverhof
David R. Geter
B. Bhaskar Gollapudi
and Heli Hollnagel). 4 APPROACHES AND PRACTICAL CONSIDERATIONS FOR THE ANALYSIS OF TOXICOGENOMICS DATA (Zhenqiang Su
Hong Fang
Weida Tong
Huixiao Hong
Roger Perkins
and Leming Shi). 5 GENOMICS IN IDENTIFYING MUTAGENIC MODE OF ACTION IN CARCINOGENESIS (Jiri Aubrecht and Ebru Caba). 6 APPLICATION OF GENOMICS FOR PREDICTING AND UNDERSTANDING THE MODE OF ACTION FOR NONGENOTOXIC CARCINOGENS (Mark R. Fielden). 7 GENOMICS IN CHARACTERIZING ENDOCRINE TOXICITY (Jorge M. Naciff and George P. Daston). 8 STUDYING ORGAN-SPECIFIC TOXICITY USING GENE-EXPRESSION PROFILING (M. Ann Mongan and Hisham K. Hamadeh). 9 TOXICOGENOMIC STUDIES IN HUMAN POPULATIONS (Cliona M. McHale
Luoping Zhang
Alan E. Hubbard
and Martyn T. Smith). 10 TOXICOGENOMICS APPLIED TO ECOLOGICAL RISK ASSESSMENT (Daniel L. Villeneuve
Dalma Martinovi¿c
and Gerald T. Ankley). 11 ANALYSIS OF TRANSCRIPTOMIC DOSE-RESPONSE DATA FOR TOXICOLOGY AND RISK ASSESSMENT (Russell S. Thomas
Longlong Yang
Harvey J. Clewell
and Melvin E. Andersen). 12 TOXICOGENOMICS AS A TOOL FOR VALIDATING ANIMAL TO HUMAN EXTRAPOLATIONS IN CHEMICAL RISK ASSESSMENT: CONCEPTS
APPLICATIONS
AND CHALLENGES (Alan Dombkowski and J. Craig Rowlands). 13 TOXICOGENOMICS AND ANIMAL ALTERNATIVES (Anne S. Kienhuis
Joost H. M. van Delft
and Jos C. S. Kleinjans). 14 TOXICOGENOMICS AND THE REGULATORY FRAMEWORK (Kathryn Gallagher
Federico M. Goodsaid
David J. Dix
Susan Y. Euling
Melissa Kramer
Nancy E. McCarroll
Julian R. Preston
Philip G. Sayre
Banalata Sen
Douglas C. Wolf
and William H. Benson). 15 STANDARDIZATION OF GENE-EXPRESSION INFORMATION FOR THE SAFETY EVALUATION: ACTIVITIES IN JAPAN (Ken-ichi Aisaki and Jun Kanno). 16 APPLYING TRANSCRIPTIONAL PROFILING IN DRUG SAFETY EVALUATION (Lois D. Lehman-McKeeman and William R. Foster). 17 REFRAMING THE RISK ASSESSMENT PARADIGM: TOWARD A SYSTEMS BIOLOGY APPROACH (Sarah N. Campion and Kim Boekelheide). INDEX.
"OMICS" TECHNOLOGIES
AND TOXICOGENOMICS: A PRIMER (Darrell R. Boverhof and B. Bhaskar Gollapudi). 2 INTRODUCTION TO HUMAN HEALTH RISK ASSESSMENT (Irene Baskerville-Abraham
Alison Willis
Bernard Gadagbui
and Lynne T. Haber). 3 PRACTICAL CONSIDERATIONS FOR THE APPLICATION OF TOXICOGENOMICS TO RISK ASSESSMENT: EARLY EXPERIENCE
CURRENT DRIVERS
AND A PATH FORWARD (Darrell R. Boverhof
David R. Geter
B. Bhaskar Gollapudi
and Heli Hollnagel). 4 APPROACHES AND PRACTICAL CONSIDERATIONS FOR THE ANALYSIS OF TOXICOGENOMICS DATA (Zhenqiang Su
Hong Fang
Weida Tong
Huixiao Hong
Roger Perkins
and Leming Shi). 5 GENOMICS IN IDENTIFYING MUTAGENIC MODE OF ACTION IN CARCINOGENESIS (Jiri Aubrecht and Ebru Caba). 6 APPLICATION OF GENOMICS FOR PREDICTING AND UNDERSTANDING THE MODE OF ACTION FOR NONGENOTOXIC CARCINOGENS (Mark R. Fielden). 7 GENOMICS IN CHARACTERIZING ENDOCRINE TOXICITY (Jorge M. Naciff and George P. Daston). 8 STUDYING ORGAN-SPECIFIC TOXICITY USING GENE-EXPRESSION PROFILING (M. Ann Mongan and Hisham K. Hamadeh). 9 TOXICOGENOMIC STUDIES IN HUMAN POPULATIONS (Cliona M. McHale
Luoping Zhang
Alan E. Hubbard
and Martyn T. Smith). 10 TOXICOGENOMICS APPLIED TO ECOLOGICAL RISK ASSESSMENT (Daniel L. Villeneuve
Dalma Martinovi¿c
and Gerald T. Ankley). 11 ANALYSIS OF TRANSCRIPTOMIC DOSE-RESPONSE DATA FOR TOXICOLOGY AND RISK ASSESSMENT (Russell S. Thomas
Longlong Yang
Harvey J. Clewell
and Melvin E. Andersen). 12 TOXICOGENOMICS AS A TOOL FOR VALIDATING ANIMAL TO HUMAN EXTRAPOLATIONS IN CHEMICAL RISK ASSESSMENT: CONCEPTS
APPLICATIONS
AND CHALLENGES (Alan Dombkowski and J. Craig Rowlands). 13 TOXICOGENOMICS AND ANIMAL ALTERNATIVES (Anne S. Kienhuis
Joost H. M. van Delft
and Jos C. S. Kleinjans). 14 TOXICOGENOMICS AND THE REGULATORY FRAMEWORK (Kathryn Gallagher
Federico M. Goodsaid
David J. Dix
Susan Y. Euling
Melissa Kramer
Nancy E. McCarroll
Julian R. Preston
Philip G. Sayre
Banalata Sen
Douglas C. Wolf
and William H. Benson). 15 STANDARDIZATION OF GENE-EXPRESSION INFORMATION FOR THE SAFETY EVALUATION: ACTIVITIES IN JAPAN (Ken-ichi Aisaki and Jun Kanno). 16 APPLYING TRANSCRIPTIONAL PROFILING IN DRUG SAFETY EVALUATION (Lois D. Lehman-McKeeman and William R. Foster). 17 REFRAMING THE RISK ASSESSMENT PARADIGM: TOWARD A SYSTEMS BIOLOGY APPROACH (Sarah N. Campion and Kim Boekelheide). INDEX.
PREFACE. CONTRIBUTORS. 1 TOXICOLOGY
"OMICS" TECHNOLOGIES
AND TOXICOGENOMICS: A PRIMER (Darrell R. Boverhof and B. Bhaskar Gollapudi). 2 INTRODUCTION TO HUMAN HEALTH RISK ASSESSMENT (Irene Baskerville-Abraham
Alison Willis
Bernard Gadagbui
and Lynne T. Haber). 3 PRACTICAL CONSIDERATIONS FOR THE APPLICATION OF TOXICOGENOMICS TO RISK ASSESSMENT: EARLY EXPERIENCE
CURRENT DRIVERS
AND A PATH FORWARD (Darrell R. Boverhof
David R. Geter
B. Bhaskar Gollapudi
and Heli Hollnagel). 4 APPROACHES AND PRACTICAL CONSIDERATIONS FOR THE ANALYSIS OF TOXICOGENOMICS DATA (Zhenqiang Su
Hong Fang
Weida Tong
Huixiao Hong
Roger Perkins
and Leming Shi). 5 GENOMICS IN IDENTIFYING MUTAGENIC MODE OF ACTION IN CARCINOGENESIS (Jiri Aubrecht and Ebru Caba). 6 APPLICATION OF GENOMICS FOR PREDICTING AND UNDERSTANDING THE MODE OF ACTION FOR NONGENOTOXIC CARCINOGENS (Mark R. Fielden). 7 GENOMICS IN CHARACTERIZING ENDOCRINE TOXICITY (Jorge M. Naciff and George P. Daston). 8 STUDYING ORGAN-SPECIFIC TOXICITY USING GENE-EXPRESSION PROFILING (M. Ann Mongan and Hisham K. Hamadeh). 9 TOXICOGENOMIC STUDIES IN HUMAN POPULATIONS (Cliona M. McHale
Luoping Zhang
Alan E. Hubbard
and Martyn T. Smith). 10 TOXICOGENOMICS APPLIED TO ECOLOGICAL RISK ASSESSMENT (Daniel L. Villeneuve
Dalma Martinovi¿c
and Gerald T. Ankley). 11 ANALYSIS OF TRANSCRIPTOMIC DOSE-RESPONSE DATA FOR TOXICOLOGY AND RISK ASSESSMENT (Russell S. Thomas
Longlong Yang
Harvey J. Clewell
and Melvin E. Andersen). 12 TOXICOGENOMICS AS A TOOL FOR VALIDATING ANIMAL TO HUMAN EXTRAPOLATIONS IN CHEMICAL RISK ASSESSMENT: CONCEPTS
APPLICATIONS
AND CHALLENGES (Alan Dombkowski and J. Craig Rowlands). 13 TOXICOGENOMICS AND ANIMAL ALTERNATIVES (Anne S. Kienhuis
Joost H. M. van Delft
and Jos C. S. Kleinjans). 14 TOXICOGENOMICS AND THE REGULATORY FRAMEWORK (Kathryn Gallagher
Federico M. Goodsaid
David J. Dix
Susan Y. Euling
Melissa Kramer
Nancy E. McCarroll
Julian R. Preston
Philip G. Sayre
Banalata Sen
Douglas C. Wolf
and William H. Benson). 15 STANDARDIZATION OF GENE-EXPRESSION INFORMATION FOR THE SAFETY EVALUATION: ACTIVITIES IN JAPAN (Ken-ichi Aisaki and Jun Kanno). 16 APPLYING TRANSCRIPTIONAL PROFILING IN DRUG SAFETY EVALUATION (Lois D. Lehman-McKeeman and William R. Foster). 17 REFRAMING THE RISK ASSESSMENT PARADIGM: TOWARD A SYSTEMS BIOLOGY APPROACH (Sarah N. Campion and Kim Boekelheide). INDEX.
"OMICS" TECHNOLOGIES
AND TOXICOGENOMICS: A PRIMER (Darrell R. Boverhof and B. Bhaskar Gollapudi). 2 INTRODUCTION TO HUMAN HEALTH RISK ASSESSMENT (Irene Baskerville-Abraham
Alison Willis
Bernard Gadagbui
and Lynne T. Haber). 3 PRACTICAL CONSIDERATIONS FOR THE APPLICATION OF TOXICOGENOMICS TO RISK ASSESSMENT: EARLY EXPERIENCE
CURRENT DRIVERS
AND A PATH FORWARD (Darrell R. Boverhof
David R. Geter
B. Bhaskar Gollapudi
and Heli Hollnagel). 4 APPROACHES AND PRACTICAL CONSIDERATIONS FOR THE ANALYSIS OF TOXICOGENOMICS DATA (Zhenqiang Su
Hong Fang
Weida Tong
Huixiao Hong
Roger Perkins
and Leming Shi). 5 GENOMICS IN IDENTIFYING MUTAGENIC MODE OF ACTION IN CARCINOGENESIS (Jiri Aubrecht and Ebru Caba). 6 APPLICATION OF GENOMICS FOR PREDICTING AND UNDERSTANDING THE MODE OF ACTION FOR NONGENOTOXIC CARCINOGENS (Mark R. Fielden). 7 GENOMICS IN CHARACTERIZING ENDOCRINE TOXICITY (Jorge M. Naciff and George P. Daston). 8 STUDYING ORGAN-SPECIFIC TOXICITY USING GENE-EXPRESSION PROFILING (M. Ann Mongan and Hisham K. Hamadeh). 9 TOXICOGENOMIC STUDIES IN HUMAN POPULATIONS (Cliona M. McHale
Luoping Zhang
Alan E. Hubbard
and Martyn T. Smith). 10 TOXICOGENOMICS APPLIED TO ECOLOGICAL RISK ASSESSMENT (Daniel L. Villeneuve
Dalma Martinovi¿c
and Gerald T. Ankley). 11 ANALYSIS OF TRANSCRIPTOMIC DOSE-RESPONSE DATA FOR TOXICOLOGY AND RISK ASSESSMENT (Russell S. Thomas
Longlong Yang
Harvey J. Clewell
and Melvin E. Andersen). 12 TOXICOGENOMICS AS A TOOL FOR VALIDATING ANIMAL TO HUMAN EXTRAPOLATIONS IN CHEMICAL RISK ASSESSMENT: CONCEPTS
APPLICATIONS
AND CHALLENGES (Alan Dombkowski and J. Craig Rowlands). 13 TOXICOGENOMICS AND ANIMAL ALTERNATIVES (Anne S. Kienhuis
Joost H. M. van Delft
and Jos C. S. Kleinjans). 14 TOXICOGENOMICS AND THE REGULATORY FRAMEWORK (Kathryn Gallagher
Federico M. Goodsaid
David J. Dix
Susan Y. Euling
Melissa Kramer
Nancy E. McCarroll
Julian R. Preston
Philip G. Sayre
Banalata Sen
Douglas C. Wolf
and William H. Benson). 15 STANDARDIZATION OF GENE-EXPRESSION INFORMATION FOR THE SAFETY EVALUATION: ACTIVITIES IN JAPAN (Ken-ichi Aisaki and Jun Kanno). 16 APPLYING TRANSCRIPTIONAL PROFILING IN DRUG SAFETY EVALUATION (Lois D. Lehman-McKeeman and William R. Foster). 17 REFRAMING THE RISK ASSESSMENT PARADIGM: TOWARD A SYSTEMS BIOLOGY APPROACH (Sarah N. Campion and Kim Boekelheide). INDEX.